小鼠 anti-人 Ig (Chain kappa), (Light Chain) Antibody (FITC)
-
- 抗原 See all Ig products
- Ig
-
抗原表位
- Chain kappa, Light Chain
-
适用
- 人
-
宿主
- 小鼠
-
克隆类型
- 单克隆
-
标记
- FITC
-
应用范围
- Flow Cytometry (FACS)
- 交叉反应 （详细）
- Species reactivity (tested):Human
- 免疫原
- Human IgG-kappa myeloma protein
- 克隆位点
- TB28-2
- 亚型
- IgG1
-
Goat anti-Human Ig (Chain kappa) antibody (Biotin)
ELISA, FACS, IHC, WB Polyclonal IgG Biotin
Goat anti-Human Ig antibodyELISA, FACS Polyclonal IgG unconjugated F(ab')2 fragment
Goat anti-Human Ig antibody (Biotin)ELISA, FACS Polyclonal IgG Biotin F(ab')2 fragment
Goat anti-Human Ig antibody (FITC)ELISA, FACS Polyclonal IgG FITC F(ab')2 fragment
Goat anti-Human Ig antibody (PE)ELISA, FACS Polyclonal IgG PE F(ab')2 fragment
Goat anti-Human Ig (Chain lambda) antibodyELISA, FACS, IHC, WB Polyclonal IgG unconjugated
Goat anti-Human Ig (Chain lambda) antibody (Biotin)ELISA, FACS, IHC, WB Polyclonal IgG Biotin
Goat anti-Human Ig (Chain lambda) antibody (FITC)ELISA, FACS, IHC Polyclonal IgG FITC
Goat anti-Human Ig (Chain kappa) antibody (TRITC)ELISA, FACS, IHC Polyclonal IgG TRITC
-
- 应用备注
- Optimal working dilution should be determined by the investigator.
- 限制
- 仅限研究用
-
- 缓冲液
- Phosphate buffered saline (PBS) containing 15 mM sodium azide and 0.2 % (w/v) high-grade protease free Bovine Serum Albumin (BSA) as a stabilizing agent.
- 储存液
- Sodium azide
- 注意事项
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- 注意事项
- DO NOT FREEZE! This product is photosensitive and should be protected from light.
- 储存条件
- 4 °C
-
- 抗原
- Ig
- 别名
- Immunoglobulin (Ig 产品)
- 背景
- Immunoglobulin classes share the same basic four polypeptide chain structure of two heavy chains (five heavy chains types) and two light chains (kappa, lambda, both having a molecular weight of 22.5 kDa). Kappa and lambda consist of a variable region and a constant region and can easily be differentiated by the antigenic properties of the constant region. The ratio of kappa to lambda is 70:30.
-
